211 related articles for article (PubMed ID: 24961346)
1. Relevance of miR-21 in HIV and non-HIV-related lymphomas.
Sekar D; Hairul Islam VI; Thirugnanasambantham K; Saravanan S
Tumour Biol; 2014 Sep; 35(9):8387-93. PubMed ID: 24961346
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas.
Thapa DR; Li X; Jamieson BD; Martínez-Maza O
PLoS One; 2011; 6(6):e20781. PubMed ID: 21698185
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
4. [Physiopathogenic aspects of HIV-associated primary brain lymphomas].
Camilleri-Broët S; Raphaël M
Rev Neurol (Paris); 2006 Jan; 162(1):57-61. PubMed ID: 16446623
[TBL] [Abstract][Full Text] [Related]
5. miR-155 regulates HGAL expression and increases lymphoma cell motility.
Dagan LN; Jiang X; Bhatt S; Cubedo E; Rajewsky K; Lossos IS
Blood; 2012 Jan; 119(2):513-20. PubMed ID: 22096245
[TBL] [Abstract][Full Text] [Related]
6. Viral oncomiR spreading between B and T cells is employed by Kaposi's sarcoma herpesvirus to induce non-cell-autonomous target gene regulation.
Rainy N; Zayoud M; Kloog Y; Rechavi O; Goldstein I
Oncotarget; 2016 Jul; 7(27):41870-41884. PubMed ID: 27248822
[TBL] [Abstract][Full Text] [Related]
7. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus.
Linnstaedt SD; Gottwein E; Skalsky RL; Luftig MA; Cullen BR
J Virol; 2010 Nov; 84(22):11670-8. PubMed ID: 20844043
[TBL] [Abstract][Full Text] [Related]
8. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas.
Anthony IC; Crawford DH; Bell JE
Brain; 2003 May; 126(Pt 5):1058-67. PubMed ID: 12690046
[TBL] [Abstract][Full Text] [Related]
9. B-cell activation induced microRNA-21 is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas.
Thapa DR; Bhatia K; Bream JH; DʼSouza G; Rinaldo CR; Wolinsky S; Detels R; Martínez-Maza O
AIDS; 2012 Jun; 26(9):1177-80. PubMed ID: 22487708
[TBL] [Abstract][Full Text] [Related]
10. Significance of microRNA 21 in gastric cancer.
Sekar D; Krishnan R; Thirugnanasambantham K; Rajasekaran B; Islam VI; Sekar P
Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):538-545. PubMed ID: 27179559
[TBL] [Abstract][Full Text] [Related]
11. A lymphomagenic role for HIV beyond immune suppression?
Dolcetti R; Gloghini A; Caruso A; Carbone A
Blood; 2016 Mar; 127(11):1403-9. PubMed ID: 26773045
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
[TBL] [Abstract][Full Text] [Related]
13. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology.
Gloghini A; Dolcetti R; Carbone A
Semin Cancer Biol; 2013 Dec; 23(6):457-67. PubMed ID: 23999127
[TBL] [Abstract][Full Text] [Related]
14. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.
Thapa DR; Hussain SK; Tran WC; Dʼsouza G; Bream JH; Achenback CJ; Ayyavoo V; Detels R; Martínez-Maza O
J Acquir Immune Defic Syndr; 2014 Jun; 66(2):229-37. PubMed ID: 24675587
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of EBV-infected cells in HIV-related lymphadenopathy: implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals.
Dolcetti R; Gloghini A; De Vita S; Vaccher E; De Re V; Tirelli U; Carbone A; Boiocchi M
Int J Cancer; 1995 Nov; 63(5):652-9. PubMed ID: 7591281
[TBL] [Abstract][Full Text] [Related]
17. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.
Fan Q; Meng X; Liang H; Zhang H; Liu X; Li L; Li W; Sun W; Zhang H; Zen K; Zhang CY; Zhou Z; Chen X; Ba Y
Protein Cell; 2016 Dec; 7(12):899-912. PubMed ID: 27815824
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
[TBL] [Abstract][Full Text] [Related]
19. Emerging pathways in the development of AIDS-related lymphomas.
Carbone A
Lancet Oncol; 2003 Jan; 4(1):22-9. PubMed ID: 12517536
[TBL] [Abstract][Full Text] [Related]
20. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.
Sandhu SK; Volinia S; Costinean S; Galasso M; Neinast R; Santhanam R; Parthun MR; Perrotti D; Marcucci G; Garzon R; Croce CM
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20047-52. PubMed ID: 23169640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
